Coherus Oncology Inc (CHRS)

Revenue

$50.94M

TTM · Period ending: · USD

CHRS logo

CHRS Revenue

Latest reported$50.94M
CHRS Revenue ($1.90M → $50.94M)
High-resolution chart · PNG

CHRS revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Revenue — Annual fiscal periods (USD)
Period endingRevenue (USD)
42,172,000
266,960,000
257,244,000
211,042,000
326,551,000
475,824,000
356,071,000
1,556,000
1,556,000
190,106,000
30,041,000
31,106,000
2,751,000
1,899,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.